These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7981958)

  • 1. Vascular interactions of lipoprotein (a).
    Liu AC; Lawn RM
    Curr Opin Lipidol; 1994 Aug; 5(4):269-73. PubMed ID: 7981958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells.
    Higazi AA; Lavi E; Bdeir K; Ulrich AM; Jamieson DG; Rader DJ; Usher DC; Kane W; Ganz T; Cines DB
    Blood; 1997 Jun; 89(12):4290-8. PubMed ID: 9192751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis.
    Hajjar KA; Gavish D; Breslow JL; Nachman RL
    Nature; 1989 May; 339(6222):303-5. PubMed ID: 2524666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipoprotein(a) in atherogenesis and thrombosis.
    Hajjar KA; Nachman RL
    Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mechanisms that may modulate the role of lipoprotein(a) in thrombosis and atherogenesis.
    Harpel PC; Borth W
    Ann Epidemiol; 1992 Jul; 2(4):413-7. PubMed ID: 1364150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of human smooth muscle cells promoted by lipoprotein(a).
    Grainger DJ; Kirschenlohr HL; Metcalfe JC; Weissberg PL; Wade DP; Lawn RM
    Science; 1993 Jun; 260(5114):1655-8. PubMed ID: 8503012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis.
    Kougias P; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
    Med Sci Monit; 2006 Jan; 12(1):RA5-16. PubMed ID: 16369478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial cells and atherosclerosis. Role of endothelium in regulation of coagulation, fibrinolysis and tonus of vascular walls].
    Kopieczna-Grzebieniak E; Grabowska-Bochenek R
    Postepy Hig Med Dosw; 1994; 48(1):19-33. PubMed ID: 8058578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) and atherogenesis.
    Liu AC; Lawn RM
    Trends Cardiovasc Med; 1994; 4(1):40-4. PubMed ID: 21244908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein-mediated functional changes in the fibrinolytic system in the genesis of atherosclerosis].
    García Frade LJ; García Avello A
    Sangre (Barc); 1991 Feb; 36(1):25-8. PubMed ID: 1649496
    [No Abstract]   [Full Text] [Related]  

  • 13. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
    Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
    Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation and fibrinolytic systems and atherogenesis].
    Takeya H; Suzuki K
    Nihon Rinsho; 1993 Aug; 51(8):1998-2003. PubMed ID: 8411663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice.
    Esenabhalu VE; Cerimagic M; Malli R; Osibow K; Levak-Frank S; Frieden M; Sattler W; Kostner GM; Zechner R; Graier WF
    Br J Pharmacol; 2002 Jan; 135(1):143-54. PubMed ID: 11786490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
    Lenzi S; Scanu A; De Caterina R
    G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a): a prothrombotic risk factor for coronary artery disease.
    Seed M; Doherty E; Stubbs P
    J Cardiovasc Risk; 1995 Jun; 2(3):206-15. PubMed ID: 7584795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.
    Lundstam U; Hurt-Camejo E; Olsson G; Sartipy P; Camejo G; Wiklund O
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1162-7. PubMed ID: 10323765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
    Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
    Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.